Funding

Afferent Pharmaceuticals raises $55M

83 Views

What does Afferent Pharmaceuticals do?

Afferent Pharmaceuticals,is a clinical stage bio-pharmaceutical company which develops medicines for treating chronic pain. It is a leader in the development of novel small molecule drugs for treating neurogenic respiratory, pain and urologic disorders. This company develops medicines for treating pain by targeting P2X3 receptors in nerve fibers.

The company is targeting sensitized nerves to treat chronic and debilitating neurogenic disorders. It is leading the development of novel, selective drugs for treating a range of debilitating neurogenic disorders which are affecting millions of patients who have limited, if any, treatment options.

How much Afferent Pharmaceuticals was funded?

The company has raised $55M in Series C funding on July 8, 2015 from the investors Fidelity Management and Research Company, New Leaf Venture Partners, Jennison Associates, Redmile Group, Partner Fund Management (PFM) and Tekla Healthcare Investors

Previous funding

  • $150k in Convertible Note on October 23, 2009
  • $23M in Series A round on December 16, 2009 from Pappas Ventures(Lead) Partner: Artthur M. Pappas, Domain Associates Partner: Jesse I. Treu, Third Rock Ventures (Lead) Partner: Kevin Starr, New Leaf Venture Partners Partner: Liam Ratcliffe and Domain Associates Partner: Jesse I. Treu
  • $5M in Venture round on January 1, 2012 fromThird Rock Ventures Partner: Kevin Starr and Domain Associates Partner: Jesse I. Treu
  • $5M in Venture round on April 1, 2013 from Pappas Ventures Partner: Artthur M. Pappas and Domain Associates Partner: Jesse I. Treu.

What is next for Afferent Pharmaceuticals?

Afferent Pharmaceuticals will use its latest funding for the advancement of the company’s first in class drug candidate AF-219 for treating pathological cough, including cough in IPF patients and for advancement of its next candidate compound to the clinic for cardiovascular and other diseases.

More about Afferent Pharmaceuticals

Afferent Pharmaceuticals was founded in 2009 by Anthony P. Ford. It has its headquarters in San Mateo, CA.

Related Posts